ReviewCancers2025

Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from Clinical Trials.

Sabrina Bakogeorgou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.